Chargement en cours...
Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy
Epithelial ovarian cancer is the sixth most common cancer among women worldwide and the first cause of death among gynecological malignancies. Most of the patients present recurrent disease and unfortunately cannot be cured. The unsatisfactory results obtained with salvage chemotherapy have elicited...
Enregistré dans:
| Publié dans: | Drug Des Devel Ther |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5983012/ https://ncbi.nlm.nih.gov/pubmed/29881257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S124447 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|